View source for 18525612. Active Agent Delivery Devices and Methods of Using the same simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)

=Active Agent Delivery Devices and Methods of Using the same=


==Organization Name==

[[:Category:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA|THE REGENTS OF THE UNIVERSITY OF CALIFORNIA]]


[[Category:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA]]

==Inventor(s)==

[[:Category:Kiana Aran of Berkeley CA (US)|Kiana Aran of Berkeley CA (US)]][[Category:Kiana Aran of Berkeley CA (US)]]

[[:Category:Jacobo Paredes of Berkeley CA (US)|Jacobo Paredes of Berkeley CA (US)]][[Category:Jacobo Paredes of Berkeley CA (US)]]

[[:Category:Niren Murthy of Berkeley CA (US)|Niren Murthy of Berkeley CA (US)]][[Category:Niren Murthy of Berkeley CA (US)]]

[[:Category:Dorian Liepmann of Lafayette CA (US)|Dorian Liepmann of Lafayette CA (US)]][[Category:Dorian Liepmann of Lafayette CA (US)]]

[[:Category:Kunwoo Lee of Albany CA (US)|Kunwoo Lee of Albany CA (US)]][[Category:Kunwoo Lee of Albany CA (US)]]

==Active Agent Delivery Devices and Methods of Using the same - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18525612 titled 'Active Agent Delivery Devices and Methods of Using the same

==Simplified Explanation==

The patent application describes active agent delivery devices designed to deliver active agent formulations into or through a mucosal layer in a subject. These devices include a power reservoir that can eject the active agent formulation at a pressure high enough to penetrate the mucosal layer. Methods of using these devices are also included in the patent application.

* The active agent delivery devices are configured to deliver active agent formulations into or through a mucosal layer in a subject.
* The devices include a power reservoir that can eject the active agent formulation at a pressure sufficient to penetrate the mucosal layer.
* Methods of using the active agent delivery devices are provided in the patent application.

== Potential Applications ==
The technology could be used in medical applications for targeted drug delivery through mucosal layers, potentially improving the effectiveness of treatments.

== Problems Solved ==
The technology addresses the challenge of delivering active agents through mucosal layers, which can be a barrier to effective treatment in some cases.

== Benefits ==
- Enhanced targeted delivery of active agents
- Improved effectiveness of treatments
- Potential for reduced side effects compared to systemic delivery methods

== Potential Commercial Applications ==
The technology could have commercial applications in pharmaceuticals, medical devices, and drug delivery systems.

== Possible Prior Art ==
Prior art in this field may include existing drug delivery devices designed for mucosal administration, such as nasal sprays or buccal patches.

== Unanswered Questions ==
=== How does the technology compare to existing mucosal delivery devices in terms of efficacy and safety? ===
The article does not provide a direct comparison between this technology and existing mucosal delivery devices.

=== Are there any limitations or potential drawbacks to using these active agent delivery devices? ===
The article does not address any limitations or potential drawbacks associated with the use of these devices.


==Original Abstract Submitted==

Provided are active agent delivery devices configured to deliver an active agent formulation into or through a mucosal layer in a subject. The active agent delivery devices include a power reservoir configured to eject the active agent formulation at a pressure sufficient to deliver the active agent formulation into or through a mucosal layer in a subject. Methods of using the subject active agent delivery devices are also provided.



[[Category:A61M31/00]]
[[Category:A61K9/00]]
[[Category:A61K39/00]]